Laboratorio Reig Jofre, S.A. (RJF.MC)

2.525 €

+0.03 (+1.00%)
Rating:
Recommendation:
-
Symbol RJF.MC
Price 2.525 €
Beta 0.984
Volume Avg. 0.02M
Market Cap 193.676M
Shares () -
52 Week Range 2.02-3.55
1y Target Est -
DCF Unlevered RJF.MC DCF ->
DCF Levered RJF.MC LDCF ->
ROE 1.11% Neutral
ROA 0.64% Neutral
Operating Margin -
Debt / Equity 71.97% Buy
P/E 42.08 Strong Buy
P/B 1.01 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Healthcare
Drug Manufacturers—Specialty & Generic
Madrid Stock Exchange

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers prescription medicines, OTCs, medical devices, and cosmetics. Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, hair, and nail health, joint health and pain, women's health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Forté Pharma brand. The company also provides CDMO and CMO services. It sells its products directly in 7 countries and through business partners in approximately 70 countries. The company was founded in 1929 and is based in Sant Joan Despí, Spain. Laboratorio Reig Jofre, S.A. is a subsidiary of Reig Jofre Investments SL.